 Wilms tumor status report National Wilms Tumor Study Committee Rapid advances understanding Wilms tumor WT management laboratory clinic Molecular genetic research loss tumor suppressor gene short arm chromosome pathways responsible development neoplasm Preconception maternal hair dyes paternal occupation environmental agents subject epidemiologic studies possible risk factors Histopathologic analyses several different common tumor types WT rubric WT so-called favorable histology FH anaplastic forms prognosis latter Clinical research management surgery chemotherapy radiation therapy RT identification risk factors Patients tumor type stage intensity treatment RT low doses National Wilms Tumor Study NWTS patients distant metastases NWTS doses Chemotherapy pre- dactinomycin vincristine Adriamycin ADR doxorubicin Adria Columbus OH high-risk patients NWTS combined modality therapy WT patients survival rates alive years treatment questions identification late effects treatments refinement therapy iatrogenic complications minimum